Literature DB >> 17195891

Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus.

Ming-Yuh Shiau1, Shih-Tzer Tsai, Kan-Jen Tsai, Ming-Lih Haung, Yi-Ting Hsu, Yih-Hsin Chang.   

Abstract

BACKGROUND: Type 1 diabetes mellitus (T1DM) is an autoimmune disorder of unknown etiology. It has been suggested that metalloproteinases (MMPs) play important roles in the development and complications of autoimmune disorders. This article presents our research on the expression or activities of MMPs in Taiwanese T1DM patients.
METHODS: Levels and activities of plasma MMP-2 and MMP-9 in patients with T1DM were investigated and compared to those of control individuals by enzyme-linked immunosorbent assay and zymography.
RESULTS: Circulatory levels and activities of MMP-2 and MMP-9 in patients with T1DM were significantly higher than those in control subjects.
CONCLUSIONS: MMP expression and activities are significantly increased in patients with T1DM. Our results not only document plasma MMPs levels and activities in the Taiwanese population (with a very low type 1 diabetic incidence), but also suggest that MMP expression and activity are elevated before the onset of complications in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17195891

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  16 in total

1.  Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy.

Authors:  L K Bhatt; Addepalli Veeranjaneyulu
Journal:  Neurol Sci       Date:  2010-03-06       Impact factor: 3.307

2.  Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients.

Authors:  Marta Toni; José Hermida; María J Goñi; Patricia Fernández; William C Parks; Estefanía Toledo; Ramón Montes; Nieves Díez
Journal:  Diabetologia       Date:  2013-12       Impact factor: 10.122

3.  The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells.

Authors:  Aaron M Dom; Adam W Buckley; Kathleen C Brown; Richard D Egleton; Aileen J Marcelo; Nancy A Proper; Donald E Weller; Yashoni H Shah; Jamie K Lau; Piyali Dasgupta
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-22       Impact factor: 4.799

4.  Apoptotic effect of mtrix metalloproteinases 9 in the development of diabetic retinopathy.

Authors:  Yu Chen; Wen Wang; Fen Liu; Luosheng Tang; Renhong Tang; Wenjie Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction.

Authors:  Ghulam Mohammad; Renu A Kowluru
Journal:  Lab Invest       Date:  2010-05-17       Impact factor: 5.662

6.  Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.

Authors:  Renu A Kowluru; Mamta Kanwar
Journal:  Free Radic Biol Med       Date:  2009-04-05       Impact factor: 7.376

7.  Effects of recombinant human relaxin upon proliferation of cardiac fibroblast and synthesis of collagen under high glucose condition.

Authors:  P Wang; H W Li; Y P Wang; H Chen; P Zhang
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

8.  Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients.

Authors:  J U Schmohl; K Daub; S N I von Ungern-Sternberg; S Lindemann; T Schönberger; T Geisler; M Gawaz; P Seizer
Journal:  Herz       Date:  2013-12-05       Impact factor: 1.443

9.  The Protective Role of Autophagy in Matrix Metalloproteinase-Mediated Cell Transmigration and Cell Death in High-Glucose-Treated Endothelial Cells.

Authors:  Chia-Lun Chao; Chun-Pin Chuang; Yen-Fen Cheng; Kueir-Rarn Lee; Yung Chang; Shun-Ping Cheng; Wan-Khey Chan; Feng-Ming Ho
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

10.  Matrix metalloproteinases in subjects with type 1 diabetes.

Authors:  Sedegheh Gharagozlian; Katja Svennevig; Hans-Jacob Bangstad; Jan-Olof Winberg; Svein Olav Kolset
Journal:  BMC Clin Pathol       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.